Literature DB >> 33748280

Custom-Made Antibiotic Cement-Coated Nail for the Treatment of Infected Bone Defect.

Guoliang Wang1, Wen Luo2, Yong Zhou1, Zhenfeng Zhu1, Zihou Zhao1, Shiyu Liu3, Jing Li4, Xuebin Feng5, Yao Zheng6, Jiahe Liang7, Jiangpu Yi7, Yong Zhang1, Yunfei Zhang1.   

Abstract

BACKGROUND: Longbone infected bone defect remains a great challenge due to multiple surgeries, long-term treatment duration, and uncertain prognosis. Treatment principles include eradication/debridement, stabilization, and antibiotic administration. An antibiotic cement-coated nail has shown great prospects due to both local antibiotic elution and stabilization of bone defects. However, the current fabrication technique remains to be improved.
METHODS: For the first time, we described a new method for custom-made cement-coated nail fabrication based on a 3D printing technique. A retrospective study of 19 consecutive patients with long bone infected bone defects from one medical center was conducted who met the inclusion and exclusion criteria from November 2016 to May 2020. The treatment involved thorough debridement, custom-made antibiotic cement-coated nail filling, and culture-specific systemic antibiotic treatment guided by a multidisciplinary team. Clinical and radiographic examinations (X-ray and CT scans) were used to evaluate bony union. Clinical and laboratory examinations were used to evaluate the infection control. The SF-36 score was used to evaluate patients' quality of life pre- and postoperatively.
RESULTS: The mean follow-up was 98.8 weeks (ranging from 40 to 192). All cases achieved infection control, 3 cases achieved bone healing after one-stage operation, and 12 cases achieved bone healing after a two-stage bone graft procedure. At the last follow-up, none of the 19 patients had infection recurrence or 1 case had failure of the protective plate. The pre- and postoperative SF-36 score showed that there were statistical differences in all the 9 aspects.
CONCLUSIONS: The precise custom-made antibiotic cement-coated intramedullary nail through the 3D printing technique used in this study is an effective strategy for the treatment of infected bone defects of long bone. This technique may help to increase the infection control rate and promote bone healing.
Copyright © 2021 Guoliang Wang et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33748280      PMCID: PMC7954627          DOI: 10.1155/2021/6693906

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  35 in total

Review 1.  Chronic posttraumatic osteomyelitis and infected nonunion of the tibia: current management concepts.

Authors:  Michael J Patzakis; Charalampos G Zalavras
Journal:  J Am Acad Orthop Surg       Date:  2005-10       Impact factor: 3.020

2.  Distal tibial nonunion treated by intramedullary reaming with external immobilization.

Authors:  C C Wu; C H Shih
Journal:  J Orthop Trauma       Date:  1996       Impact factor: 2.512

3.  Oral versus Intravenous Antibiotics for Bone and Joint Infection.

Authors:  Ho-Kwong Li; Ines Rombach; Rhea Zambellas; A Sarah Walker; Martin A McNally; Bridget L Atkins; Benjamin A Lipsky; Harriet C Hughes; Deepa Bose; Michelle Kümin; Claire Scarborough; Philippa C Matthews; Andrew J Brent; Jose Lomas; Roger Gundle; Mark Rogers; Adrian Taylor; Brian Angus; Ivor Byren; Anthony R Berendt; Simon Warren; Fiona E Fitzgerald; Damien J F Mack; Susan Hopkins; Jonathan Folb; Helen E Reynolds; Elinor Moore; Jocelyn Marshall; Neil Jenkins; Christopher E Moran; Andrew F Woodhouse; Samantha Stafford; R Andrew Seaton; Claire Vallance; Carolyn J Hemsley; Karen Bisnauthsing; Jonathan A T Sandoe; Ila Aggarwal; Simon C Ellis; Deborah J Bunn; Rebecca K Sutherland; Gavin Barlow; Cushla Cooper; Claudia Geue; Nicola McMeekin; Andrew H Briggs; Parham Sendi; Elham Khatamzas; Tri Wangrangsimakul; T H Nicholas Wong; Lucinda K Barrett; Abtin Alvand; C Fraser Old; Jennifer Bostock; John Paul; Graham Cooke; Guy E Thwaites; Philip Bejon; Matthew Scarborough
Journal:  N Engl J Med       Date:  2019-01-31       Impact factor: 91.245

4.  Management of adult osteomyelitis.

Authors:  R A Colyer
Journal:  J Indiana State Med Assoc       Date:  1982-06

5.  The treatment of chronic open osteomyelitis of the tibia in adults.

Authors:  Rodney K Beals; Richard E Bryant
Journal:  Clin Orthop Relat Res       Date:  2005-04       Impact factor: 4.176

6.  Antibiotic cement nail for the treatment of posttraumatic intramedullary infections of the tibia: midterm results in 10 cases.

Authors:  Marcin Krzysztof Wasko; Olivier Borens
Journal:  Injury       Date:  2013-06-05       Impact factor: 2.586

7.  Comparing the use of preformed vs hand-made antibiotic spacer cement in two stages revision of hip periprosthetic infection.

Authors:  Giuseppe Rollo; Giandomenico Logroscino; Daniele Stomeo; Raffaele Cioffi; Vittorio Calvisi; Luigi Meccariello
Journal:  J Clin Orthop Trauma       Date:  2020-08-17

8.  Infection following intramedullary nailing of long bones. Diagnosis and management.

Authors:  M J Patzakis; J Wilkins; D A Wiss
Journal:  Clin Orthop Relat Res       Date:  1986-11       Impact factor: 4.176

9.  Commercially available antibiotic-laden PMMA-covered locking nails for the treatment of fracture-related infections - A retrospective case analysis of 10 cases.

Authors:  Alberto Jorge-Mora; Samer Amhaz-Escanlar; Sabela Fernandez-Pose; Adrián García-Iglesias; Fermín Mandia-Mancebo; Eloi Franco-Trepat; María Guillán-Fresco; Jesús Pino-Minguez
Journal:  J Bone Jt Infect       Date:  2019-07-05

10.  A novel technique for fabricating antibiotic-coated intramedullary nails using an antibiotic-loaded calcium sulphate hydroxyapatite bio-composite, Cerament-V.

Authors:  Luke D Hughes; Anoop Anugraha; Anand Pillai
Journal:  J Surg Case Rep       Date:  2019-11-29
View more
  1 in total

Review 1.  Recent advances in the local antibiotics delivery systems for management of osteomyelitis.

Authors:  Reem Khaled Wassif; Maha Elkayal; Rehab Nabil Shamma; Seham A Elkheshen
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.